Century-long protein hunt ends with chance discovery on bone biology

May 10, 2012 in Medical research

(Medical Xpress) -- In 1883, Swedish chemist Olof Hammarsten discovered that milk proteins called caseins contain not just the known building blocks of proteins, but also the chemical phosphate. It was the first hint that phosphates – which are now considered critical regulators of protein function -- are tacked onto proteins. Today, scientists know that enzymes called kinases can control protein function by attaching phosphates to proteins produced inside cells. Hundreds of kinases have been discovered and characterized, but the kinase that phosphorylates casein was never pinned down—until now.

Howard Hughes Medical Institute scientists have identified and isolated that elusive enzyme. In a study published online May 10, 2012, in Science Express, they report that they have uncovered the enzyme that transfers not only to like casein, but also to proteins found in bones and teeth enamel.

“We solved this scientific puzzle that dates back to the 19th century,” says Howard Hughes Medical Institute vice president and chief scientific officer Jack E. Dixon, lead researcher of the study. “We also ended up stumbling onto this connection between this kinase and biomineralization.”

Dixon, whose lab is based at the University of California, San Diego, studies kinases, the enzymes that add phosphates to proteins, and phophatases, which remove phosphates. While most kinases are located within the cell, in the 1980s researchers started reporting that they’d detected kinase activity (i.e. phosphorylated proteins) outside of cells. In 2008, Kenneth Irvine, an HHMI investigator at Rutgers, was studying a called four-jointed, which is important in the development of fruit flies. Irvine demonstrated that four-jointed had kinase activity, even though the protein was unlike any other traditional kinase. Moreover, the protein localized to the Golgi apparatus, a compartment within the cell where proteins are sorted and packaged.

“It was not clear to us that any of the approximately 580 traditional kinases had signal sequences which would allow them to end up in the same cellular compartment as casein, which was known to be secreted,” says Dixon. So, Dixon, in collaboration with Nick Grishin, an HHMI investigator at the University of Texas Southwestern Medical Center, searched databases of protein sequences to find human proteins that resembled four-jointed. They identified a family of proteins -- so little studied that its only name was Fam20 (for family 20) -- with sequence similarity to four-jointed, and found that the Fam20 A, B, and C proteins had amino acid sequences that would direct them to same part of the Golgi apparatus as the casein protein. Fam20C phosphorylated casein and many peptides on a specific amino acid sequence motif.

But discovering that Fam20C is the kinase that acts on casein wasn’t the end of the story. As Dixon’s group looked through the scientific literature, they found that mutations in Fam20C had previously been found in patients with Raine syndrome, a rare and fatal disease in which developing bones become too dense. To understand this link between Fam20C and Raine syndrome, Dixon developed cell lines that produce Fam20C containing mutations that affect the same that had been implicated in the disease.

“It turns out that every single one of these mutations inactivated the kinase and prevented it from being secreted,” says Dixon. And the targeted amino acid sequence that the researchers had nailed down earlier wasn’t just found in casein—it was found in dental matrix protein, osteopontin, and bone sialophosphoprotein, among others. All these proteins are involved in enamel and bone formation.

“In the end, what we’ve discovered isn’t just the casein kinase,” Dixon says. “It’s a whole new branch on the kinase tree, a branch that seems to play very important roles in bone and teeth formation.”

Phosphates are often used by proteins to bind calcium, a key ingredient of bones, teeth, and milk. So Dixon thinks the phosphorylation by Fam20C generates a calcium-binding site that is critical in the formation of bone and teeth. When the kinase is mutated, the bones or teeth don’t develop correctly.

Next on the scientists’ to-do list is uncovering the functions of the other Fam20 proteins—Fam20A and Fam20B, as well as working out the exact mechanism by which Fam20C works.

“This is the end of one scientific mystery,” says Dixon, “but it also opens up a whole new area of kinase biology for us to explore.”

More information: "Secreted Kinase Phosphorylates Extracellular Proteins that Regulate Biomineralization," by V.S. Tagliabracci et al., Science Express (2012).

Provided by Howard Hughes Medical Institute search and more info website

4.3 /5 (3 votes)  

Rank 4.3 /5 (3 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

Medical research created 8 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Medical research created May 17, 2013 | popularity 4 / 5 (4) | comments 0 | with audio podcast

SUMO wrestling cells reveal new protective mechanism target for stroke

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

Medical research created May 17, 2013 | popularity 5 / 5 (1) | comments 0

How serotonin receptors can shape drug effects, from LSD to migraine medication

New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast

Preventing blood poisoning

Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...